Critical State of "Remission-Recurrence" of Ulcerative Colitis
ConditionUlcerative Colitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorBeijing Hospital of Traditional Chinese Medicine
About this trial
This study will recruit 100 patients with ulcerative colitis in remission for a 6-month non intervention follow-up observation. During the study, their conditions will be recorded truthfully, including general information, disease-related symptoms and signs, inflammatory bowel disease questionnaire, anxiety self-assessment scale, depression self-assessment scale, etc., every month. Collect blood, urine, and stool samples from patients every month for examination. Follow up for each subject until their condition recurs.
Eligibility criteria
Qualifiers
Patients who meet the criteria based on the clinical characteristics of ulcerative colitis patients in the "remission recurrence" critical state, combined with clinical symptoms, are diagnosed with ulcerative colitis through imaging, endoscopy, laboratory, and histopathological examinations;
Patients with comprehensive laboratory testing indicators.
Disqualifiers
Patients with incomplete case information records;
Patients who have not completed serological tests;
Complications including intestinal obstruction, intestinal perforation, toxic megacolon, and severe local stenosis;
Diagnosed or suspected patients with coexisting uncertain colitis, infectious or ischemic colitis;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
100 Participants
are grouped into 1 trial groupLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Beijing Hospital of Traditional Chinese Medicine, Capital Medical UniversityRecruiting100010, Dongcheng, Beijing Municipality
China
ChinaSponsors and collaborators
Source ClinicalTrials.gov